Aetna Multiple Sclerosis Claim Denied: Appeal

Multiple sclerosis is a chronic, progressive neurological disease that demands consistent, often expensive treatment. Disease-modifying therapies (DMTs), infusion treatments, and specialist care are not luxuries — they are medically necessary for slowing progression and preserving function. If Aetna denied your MS-related claim, you are not alone, and you have real options.

Why Aetna Denies MS Claims

Aetna uses clinical policy bulletins (CPBs) to govern coverage for MS treatments. Common denial reasons include:

Step therapy requirements. Aetna often requires members to try and fail one or more lower-cost DMTs before approving higher-efficacy drugs like ocrelizumab (Ocrevus), natalizumab (Tysabri), or alemtuzumab (Lemtrada). If your neurologist prescribed a high-efficacy drug first, expect pushback.

Medical necessity disputes. Aetna may argue that your current level of disability or relapse frequency does not meet their threshold for the requested therapy. They rely on clinical benchmarks like EDSS scores, annualized relapse rates, and MRI activity findings.

Off-label use denials. Certain treatments used in MS — including some IV medications — may be denied as experimental or investigational if the specific indication is not listed in Aetna's CPB.

Dosing and frequency disputes. For infusion therapies like Ocrevus, Aetna may approve the drug but dispute the dosing schedule, leaving members without timely treatment.

Prior Authorization Denied: How to Appeal" class="auto-link">Prior authorization failures. If your provider submitted incomplete documentation, missing MRI reports, neurologist notes, or prior treatment history, Aetna may deny for lack of medical necessity documentation rather than the clinical question itself.

What Aetna's Clinical Criteria Look Like

Aetna's CPB for MS DMTs typically requires:

• Confirmed MS diagnosis (relapsing-remitting, secondary progressive, or primary progressive)
• Documentation of prior DMT trials for step therapy cases
• Neurologist attestation (not a general practitioner)
• Recent MRI evidence of disease activity
• EDSS or functional scoring in some cases

For high-efficacy agents, Aetna may specifically require that you have had two or more relapses in the prior two years or documented MRI progression despite existing therapy.

How to Appeal Aetna's MS Denial

Step 1: Request the complete denial letter and clinical criteria. Aetna must provide a written denial explaining the specific clinical reason and the criteria applied. Get a copy of the applicable CPB.

Step 2: Request a peer-to-peer review. Your neurologist can call Aetna's medical reviewer directly to discuss the clinical rationale. This is often the fastest path to reversal — MS specialists tend to be persuasive when speaking to peers. Ask for the peer-to-peer within 5–10 business days of the denial.

Step 3: File a formal internal appeal. Under the ACA, you have at least 180 days to file an internal appeal. Submit:

• A detailed letter from your neurologist explaining why this specific therapy is medically necessary
• Current MRI reports and neurology notes
• Evidence of prior therapy failures if step therapy applies
• Published clinical guidelines (National MS Society, AAN) supporting the treatment

Step 4: Request an expedited appeal for urgent cases. If delaying treatment could cause irreversible neurological damage, request an expedited appeal. Aetna must respond within 72 hours.

Step 5: Escalate to External Independent Review: Complete Guide" class="auto-link">external review. If Aetna upholds the denial internally, request an independent external review. An IROs) Explained" class="auto-link">Independent Review Organization (IRO) will evaluate whether the denial meets clinical standards — and they overturn insurers at meaningful rates. File directly with Aetna or your state insurance department.

External Resources and Escalation Options

• State insurance department: File a complaint if Aetna violates appeal timelines or denies without adequate explanation.
• National MS Society: Provides advocacy support and connects members with insurance navigators at mssociety.org.
• CMS complaint: If you are on Medicare Advantage through Aetna, file a complaint at medicare.gov or call 1-800-MEDICARE.

Documentation Tips

The single most important thing you can do is ensure your neurologist writes a letter that uses Aetna's own clinical language — referencing EDSS scores, relapse rates, and MRI findings in the format their reviewers expect. Generic letters fail. Letters that mirror Aetna's criteria succeed.

If Aetna denied based on step therapy and you have a medical reason why the required first-line drug is contraindicated — a prior adverse reaction, liver disease, cardiac history — document it explicitly. Aetna must consider contraindications as exceptions to step therapy requirements.

Fight Back With ClaimBack

ClaimBack's free AI tool drafts a professional appeal letter in minutes, tailored to your insurer and denial reason. Don't let a denial be the final word.

Fight your denial at ClaimBack →

Related Reading:

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• What Is Peer-to-Peer Review?